Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Elizabeth Warren asks...

    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-07-05T09:10:52+05:30  |  Updated On 16 Aug 2021 1:05 PM IST

    In a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door influence-peddling smacks of corruption."


    U.S: U.S. Senator Elizabeth Warren urged former U.S. Food and Drug Administration Commissioner Scott Gottlieb to immediately step down from Pfizer Inc's (PFE.N) board, three months after his departure from the health regulator.


    In a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door influence-peddling smacks of corruption."


    Gottlieb, who won bipartisan support for his efforts to curb use of flavored e-cigarettes by youths, stepped down from the FDA in April, a role he had held since May 2017.


    He was named to Pfizer's board last Thursday and was added to the board's regulatory and compliance as well as the science and technology committees.


    Warren added that such moves could make Americans cynical and distrustful about whether high-level officials from President Donald Trump's administration are working for the people or for future corporate employers.


    Gottlieb said in a tweet on Tuesday that he had a productive relationship with Warren while he was at the FDA and would respond to her letter privately.


    When asked to comment on Senator Warren's letter, Pfizer pointed Reuters to the company's announcement on Thursday.


    Also Read: Former USFDA boss Scott Gottlieb to join Pfizer board

    corruptiondonal trumpe-cigarettesElizabeth WarrenPfizerpharmapharma newspharma news indiaquit pfizer boardScott GottliebSenator WarrenTwitterUSFDA
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok